The landscape of managing diabetes is advancing with mazdutide vs tirzepatide the introduction of GLP-1 patches . These innovative devices offer a potentially less invasive alternative to shots for individuals dealing with diabetes 2. They deliver a GLP-1 agonist directly through the dermis , avoiding the need for daily injections and potentially i